14 Apr 2020 14:30
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
| |||
Period of return | From: | 1 October 2019 | To: | 31 March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | SOP: 792,700 ordinary shares of 10 pence | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 ordinary shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 0 ordinary shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 792,700 ordinary shares of 10 pence | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") | |||
Period of return | From: | 1 October 2019 | To: | 31 March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | LTIP: 102,714 ordinary shares of 10 pence
| |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | LTIP: 0 ordinary shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | LTIP: 15,014 ordinary shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | LTIP: 87,700 ordinary shares of 10 pence | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") | |||
Period of return | From: | 1 October 2019 | To: | 31 March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | MIP: 770,393 ordinary shares of 10 pence | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | MIP: 1,000,000 ordinary shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | MIP: 8,391 ordinary shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | MIP: 1,519,989 ordinary shares of 10 pence | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") | |||
Period of return | From: | 1 October 2019 | To: | 31 March 2020 |
Balance of unallotted securities under scheme(s) from previous return: | EIP: 1,541,128 ordinary shares of 10 pence | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | EIP: 0 ordinary shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | EIP: 8,742 ordinary shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | EIP: 1,102,558 ordinary shares of 10 pence | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
LEI: 549300BNS685UXH4JI75
Hikma Pharmaceuticals (HIK)